Pheonix Research - Editorial Index
Editorial analysis anchored to industries, segments, and the market intelligence behind them.
The FDA's proposed GRAS rule creates no premarket review and sets no nanotechnology standard. It does something narrower and more damaging to a specific business model: it removes the exemption that most nanoencapsulated ingredients have been relying on — that the parent substance was already GRAS.
Hormel sold 2.3% fewer pounds in fiscal 2025 and took 1.6% more money for them, while Tyson's branded retail volume grew 2.4% against a category down 1.5%. Branded, prepared protein is now the only part of the meat business that grows while the category shrinks — and the commodity underneath still sets the margin.
Asia-Pacific's health and wellness food market compounds at 10.9% while regulators in Washington, London and New Delhi tighten what a food may call itself. The stricter the definition, the more the claim is worth to whoever can still legally make it.
